Drugs / AZD5122
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00984477 | Sep → Nov 2009 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD5122 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00984477 ↗ |
| Known as | SRT-3109 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095219 ↗ |
| Modality | Small molecule | — CHEMBL5095219 ↗ |
| Route | Oral | “A single dose of oral suspension” NCT00984477 ↗ |